Clinical Trial Detail

NCT ID NCT03002623
Title CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

thyroid gland papillary carcinoma

tall cell variant papillary carcinoma

thyroid gland Hurthle cell carcinoma

thyroid gland cancer

Therapies

CUDC-907

Age Groups: senior adult

No variant requirements are available.